The initiative is established by Boehringer Ingelheim and supported by GALVmed Nairobi, Kenya – 4 July 2018– Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today the launch […]
Arusha, 1st October 2018 – The first licences for a veterinary vaccine submitted for registration under the East African Community’s Mutual Recognition Procedure (MRP) have been issued. Obtaining approval to […]
(10 August 2018, Edinburgh, UK)-The Board of GALVmed is pleased to announce the appointment of Dr. Carolin Schumacher as the new Chief Executive Officer of GALVmed. Carolin was appointed following […]
EDINBURGH, UK, February 21, 2018 – As the global US $30m Brucellosis Vaccine Prize competition enters its second phase, organisers are calling on commercial and academic organisations to join forces […]
26 January, 2018, Edinburgh, U.K.: Bill Gates, co-chair of the Bill & Melinda Gates Foundation, will today visit the University of Edinburgh with the Secretary of State for International Development […]
Arecor and its partner, non-profit company, Global Alliance for Livestock Veterinary Medicines (GALVmed), have successfully stabilised liquid formulations of vaccines to combat two major diseases of livestock across the developing […]
(The following press release was issued by the Kenyan Ministry of Agriculture Livestock and Fisheries on November 24, 2017.) A new agency to oversee the regulation of all veterinary medicinal […]
EDINBURGH, UK, September 26, 2017 – Additional prizes have been awarded in a global US $30 million competition aimed at incentivising the development of a vaccine that is efficacious, safe […]
A fresh outbreak of brucellosis in India serves as a stark reminder of the need for effective control measures. In July, more than 50 cows were reported to have been […]
Prizes awarded to three organisations at the midway point of Phase 1 EDINBURGH, UK, July 6, 2017 – Three organisations have each been awarded prizes of US $100,000 following their […]
